Recursion Pharmaceuticals, Inc. RXRX 股票预测
Recursion Pharmaceuticals, Inc.的AI驱动价格预测与分析 · 已更新 五月 29, 2026
AI 90天预测
持有
7天
30天
90天
AI置信度: 39% 斯皮尔曼相关性
五月 29, 2026
价格图表
正在加载图表...
关键统计数据
市值
$1.90B
市净率
1.86x
每股收益
$-0.76
股本回报率
-12.0%
净利率
-1199.0%
收入
$66M
流动比率
5.47x
资产负债率
0.31x
关于 Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. (RXRX) 在Life Sciences行业运营，具体属于Biological Products, (No Diagnostic Substances)业务. .
Ramon Martin Chavez (born c. 1964) is an American investment banker and entrepreneur. He is vice chairman and partner of Sixth Street Partners. Previously, he served in a variety of senior roles at Goldman Sachs, including chief information officer (2014–2017), chief financial officer, and global co-head of the firm's Securities Division. Marty was also a partner and member of Goldman's management committee. He was the chief technology officer and co-founder of Quorum Software Systems and CEO and co-founder of Kiodex. …
Biological Products, (No Diagnostic Substances) 同行公司
| 公司 | 股票代码 | AI信号 | 市值 | 市盈率 |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $188M | -x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $1M | -x |
| Arcellx, Inc. | ACLX | ██% | $6.73B | -x |
| Alpha Cognition Inc. | ACOG | ██% | $135M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13.2x |
| Adma Biologics, Inc. | ADMA | ██% | $1.85B | 11.2x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $2.42B | -x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1.8x |
| Agenus Inc | AGEN | ██% | $135M | 2.1x |
| Agentix Corp. | AGTX | ██% | $840K | -x |
| Aim Immunotech Inc. | AIM | ██% | $6M | -x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $240M | -x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $35M | -x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $749M | -x |
| Alvotech | ALVO | ██% | $1.05B | -x |
| Amgen Inc | AMGN | ██% | $181.77B | 23.3x |
| Apogee Therapeutics, Inc. | APGE | ██% | $6.15B | -x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $51.73B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $298M | -x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $385M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0.2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $89M | -x |
| Atyr Pharma Inc | ATYR | ██% | $53M | -x |
| Aura Biosciences, Inc. | AURA | ██% | $772M | -x |
| Autolus Therapeutics Plc | AUTL | ██% | $498M | -x |
| Anavex Life Sciences … | AVXL | ██% | $281M | -x |
| Bioatla, Inc. | BCAB | ██% | $7M | -x |
| Biocardia, Inc. | BCDA | ██% | $10M | -x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $9M | -x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.26B | -x |
| Black Diamond Therapeutics, … | BDTX | ██% | $127M | -x |
| Beam Therapeutics Inc. | BEAM | ██% | $3.38B | -x |
| Biogen Inc. | BIIB | ██% | $28.85B | 21.0x |
| Biontech Se | BNTX | ██% | $24.26B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $616M | -x |
| Candel Therapeutics, Inc. | CADL | ██% | $608M | -x |
| C4 Therapeutics, Inc. | CCCC | ██% | $455M | -x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1.0x |
| Creative Medical Technology … | CELZ | ██% | $8M | -x |
| Cero Therapeutics Holdings, … | CERO | ██% | $790K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $1.01B | -x |
| Compugen Ltd | CGEN | ██% | $249M | 3.5x |
| Cg Oncology, Inc. | CGON | ██% | $5.48B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $105M | -x |
| Coherus Oncology, Inc. | CHRS | ██% | $245M | 1.3x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $4M | -x |
| Cellectis S.A. | CLLS | ██% | $354M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $429M | -x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1.5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $130M | -x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $141M | -x |
| Curis Inc | CRIS | ██% | $23M | -x |
| Crispr Therapeutics Ag | CRSP | ██% | $5.41B | -x |
| Champions Oncology, Inc. | CSBR | ██% | $81M | -x |
| Cel Sci Corp | CVM | ██% | $22M | -x |
| Dbv Technologies S.A. | DBVT | ██% | $1.13B | -x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $578M | -x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.34B | -x |
| Precision Biosciences Inc | DTIL | ██% | $180M | -x |
| Dyadic International Inc | DYAI | ██% | $29M | -x |
| Editas Medicine, Inc. | EDIT | ██% | $531M | -x |
| Eloxx Pharmaceuticals, Inc. | ELOX | ██% | $3M | -x |
| Elutia Inc. | ELUT | ██% | $50M | 1.0x |
| Engene Therapeutics Inc. | ENGN | ██% | $124M | -x |
| Entera Bio Ltd. | ENTX | ██% | $63M | -x |
| Viskase Holdings, Inc. | ENZN | ██% | $38M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $46M | -x |
| Evaxion A/S | EVAX | ██% | $33M | -x |
| Exelixis, Inc. | EXEL | ██% | $12.81B | 15.4x |
| Exozymes Inc. | EXOZ | ██% | $83M | -x |
| Fate Therapeutics Inc | FATE | ██% | $330M | -x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $518M | -x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $343M | -x |
| Finch Therapeutics Group, … | FNCH | ██% | $12M | 0.5x |
| Finch Therapeutics Group, … | FNCHQ | ██% | $12M | 0.5x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $166.96B | 18.1x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.66B | -x |
| Genenta Science S.P.A. | GNTA | ██% | $24M | -x |
| Green Planet Bio … | GPLB | ██% | N/A | -x |
| Greenland Mines Ltd | GRML | ██% | $43M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $7.89B | 22.6x |
| Humacyte, Inc. | HUMA | ██% | $289M | -x |
| Immunitybio, Inc. | IBRX | ██% | $7.88B | -x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $231M | -x |
| Imagenebio, Inc. | IMA | ██% | $66M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.47B | -x |
| Immatics N.V. | IMTX | ██% | $1.54B | -x |
| Immunovant, Inc. | IMVT | ██% | $6.79B | -x |
| In8bio, Inc. | INAB | ██% | $18M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6.8x |
| Mink Therapeutics, Inc. | INKT | ██% | $59M | -x |
| Inmune Bio, Inc. | INMB | ██% | $37M | -x |
| Intensity Therapeutics, Inc. | INTS | ██% | $11M | -x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.80B | -x |
| Century Therapeutics, Inc. | IPSC | ██% | $441M | -x |
| Invivyd, Inc. | IVVD | ██% | $322M | -x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $23M | -x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $121M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.28B | -x |
| Krystal Biotech, Inc. | KRYS | ██% | $9.10B | 40.4x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.69B | -x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $516M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $332M | -x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $244M | -x |
| Atyr Pharma Inc | LIFE | ██% | $1.85B | -x |
| Liminatus Pharma, Inc. | LIMN | ██% | $7M | -x |
| Leonabio, Inc. | LONA | ██% | $90M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $381M | -x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.46B | -x |
| Mesoblast Ltd | MESO | ██% | $1.99B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $986M | -x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $51M | -x |
| Molecular Partners Ag | MOLN | ██% | $170M | -x |
| Moderna, Inc. | MRNA | ██% | $18.73B | -x |
| Neurocrine Biosciences Inc | NBIX | ██% | $15.92B | 23.8x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0.1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $333M | -x |
| Novavax Inc | NVAX | ██% | $1.80B | -x |
| Ocugen, Inc. | OCGN | ██% | $467M | -x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $88M | -x |
| Palisade Bio, Inc. | PALI | ██% | $355M | -x |
| Passage Bio, Inc. | PASG | ██% | $19M | -x |
| Vaxcyte, Inc. | PCVX | ██% | $7.42B | -x |
| Biomx Inc. | PHGE | ██% | $13M | -x |
| Pluri Inc. | PLUR | ██% | $24M | -x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $168M | 11.0x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $9M | -x |
| Prime Medicine, Inc. | PRME | ██% | $641M | -x |
| Prokidney Corp. | PROK | ██% | $553M | -x |
| Pelthos Therapeutics Inc. | PTHS | ██% | $89M | -x |
| Qiagen N.V. | QGEN | ██% | $7.94B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $22M | 2.6x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $692M | -x |
| Repligen Corp | RGEN | ██% | $6.99B | 136.0x |
| Regenxbio Inc. | RGNX | ██% | $362M | -x |
| Relay Therapeutics, Inc. | RLAY | ██% | $3.06B | -x |
| Revolution Medicines, Inc. | RVMD | ██% | $31.52B | -x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.90B | -x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $275M | -x |
| Sana Biotechnology, Inc. | SANA | ██% | $890M | -x |
| Scilex Holding Co | SCLX | ██% | $63M | -x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $86M | -x |
| Solid Biosciences Inc. | SLDB | ██% | $722M | -x |
| Silexion Therapeutics Corp | SLXN | ██% | $2M | -x |
| Senti Biosciences Holdings, … | SNTI | ██% | $30M | -x |
| Scholar Rock Holding … | SRRK | ██% | $5.87B | -x |
| Surrozen, Inc./De | SRZN | ██% | $301M | -x |
| Sutro Biopharma, Inc. | STRO | ██% | $484M | -x |
| Protara Therapeutics, Inc. | TARA | ██% | $256M | -x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.56B | -x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $71M | -x |
| Bio-Techne Corp | TECH | ██% | $8.09B | 73.8x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $587M | -x |
| Instil Bio, Inc. | TIL | ██% | $55M | -x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $189M | -x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3.5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.69B | -x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0.5x |
| Tevogen Bio Holdings … | TVGN | ██% | $33M | -x |
| Twist Bioscience Corp | TWST | ██% | $4.16B | -x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $304M | 45.1x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6.7x |
| Valneva Se | VALN | ██% | $593M | -x |
| Vericel Corp | VCEL | ██% | $1.70B | 79.2x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.54B | -x |
| Vivosim Labs, Inc. | VIVS | ██% | $3M | -x |
| Vor Biopharma Inc. | VOR | ██% | $811M | -x |
| Vaxart, Inc. | VXRT | ██% | $157M | 4.2x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $233M | -x |
| Windtree Therapeutics Inc … | WINT | ██% | $340K | -x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $407M | -x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $14M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $17M | -x |
| Zura Bio Ltd | ZURA | ██% | $408M | -x |
常见问题
-
Recursion Pharmaceuticals, Inc.是值得买入的好股票吗？
我们的AI每天分析Recursion Pharmaceuticals, Inc.。查看上方信号获取最新建议。投资前请务必自行研究。
-
Recursion Pharmaceuticals, Inc.的预测有多准确？
我们的AI在该股票的斯皮尔曼相关性达到39%，每天分析的4,000+只股票中平均准确率超过67%。
-
预测多久更新一次？
Recursion Pharmaceuticals, Inc.的预测使用最新市场数据和AI模型每天更新。
想要Recursion Pharmaceuticals, Inc.的更深入分析吗？
在Intratio上查看完整的机构级分析 →AI预测基于历史模式，不应作为投资决策的唯一依据。过往表现不保证未来结果。请务必自行研究。